Patient Portal Technologies, Inc.
$0.00$0.00 (0.0%)
Patient Portal Technologies, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
OTC · BNKL · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Bionik Laboratories Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Bionik Laboratories Corp. operates as a robotics firm, focusing on the innovation, development, and market introduction of advanced solutions for physical rehabilitation, prosthetic devices, and assistive robotics. The company's product range features the InMotion Robots, a comprehensive collection of robotic therapy tools. This includes the InMotion ARM, an intelligent and interactive therapeutic system grounded in scientific evidence, adept at perceiving patient movements and physical restrictions. Additionally, the InMotion ARM/HAND is offered to facilitate therapies requiring reaching with grasping and releasing actions, alongside individual hand manipulations. Rounding out their offerings is the InMotion Connect platform, which integrates a hardware unit that interfaces with an InMotion Robot, coupled with a subscription for the InMotion Connect Pulse service. Established in 2010, Bionik Laboratories Corp. maintains its principal operations in Watertown, Massachusetts.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:32 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00$0.00 (0.0%)
Patient Portal Technologies, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
9 Meters Biopharma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
$0.00$0.00 (0.0%)
BIMI International Medical Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
$0.00$0.00 (0.0%)
Oracle Healthcare Acquisition Corp.: Financial Services · Shell Companies.
$0.00$0.00 (0.0%)
FusionPharm, Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00$0.00 (0.0%)
BG Medicine, Inc.: Healthcare · Medical - Instruments & Supplies.
$0.00$0.00 (0.0%)
PrimeCare Systems, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Millennium Sustainable Ventures Corp.’s quoted price sits in the lower half of its reported 52-week range, 75.0% below the high.